Target intelligence / Profile preview

African swine fever virus antigen (ASFV antigen)

Target
ASFV antigen
Molecular classification
Viral protein, Capsid protein, Envelope protein, Glycoprotein, Chaperone
01

Overview

African swine fever virus (ASFV) antigens are a collection of proteins encoded by the ASFV genome that are essential for viral structure, replication, and interaction with the host immune system. The most significant antigen is the major capsid protein p72, encoded by the B646L gene, which is highly conserved and serves as the primary target for diagnostic detection and genotype classification [UniProt: P0C962]. Other key antigens include p54 (E183L) and p30 (CP204L), which facilitate viral attachment and internalization into porcine macrophages, the virus's primary target cells. Additionally, the CD2v protein (EP402R) is involved in hemadsorption and helps the virus evade host immune responses by mimicking host T-cell receptors. These antigens are the focus of intensive research for the development of vaccines, including live-attenuated, subunit, and DNA-based candidates, to control the spread of this highly lethal disease [NCBI: ]. However, the complexity of the ASFV virion and its ability to inhibit interferon signaling pose significant challenges to achieving effective and safe immunization.

Other names
Major capsid protein p72Attachment protein p54Internalization protein p30Hemadsorption protein CD2vChaperone protein pB602LB646LE183LCP204LEP402Rp12p22
02

Mechanism of action

Induction of humoral and cellular immune responses to neutralize viral particles and inhibit infection of porcine macrophages.

03

Biological functions

Viral attachmentViral entryViral assemblyImmune evasionHemadsorptionHost cell interaction
04

Disease associations

African swine feverInfection
05

Safety considerations

Antibody-dependent enhancement (ADE)Reversion to virulence in live-attenuated vaccines [NCBI: ]Genetic variability among ASFV genotypesLack of cross-protection between genotypes
06

Interacting drugs

ASFV-G-ΔI177L (experimental vaccine)

4 more in the full profile.

07

Biomarkers

Anti-p72 antibody titerAnti-p30 antibody titerASFV p72 genomic DNAp30 protein expression levels

Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.

Beyond the preview

Go deeper on African swine fever virus antigen (ASFV antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on African swine fever virus antigen (ASFV antigen).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call